PD Dr. Dr. med.

Patrick M.

Meyer Sauteur

2021: Habilitation (PD) «The B cell response to Mycoplasma pneumoniae in childhood pneumonia»,Prof. M. Grotzer, Medizinische Fakultät, Universität Zürich, Schweiz
2018: Naturwissenschaftliche Doktorarbeit (PhD, summa cum laude) «Antibody responses to Mycoplasma pneumoniae: protecting against and triggering disease», Prof. A.M.C. van Rossum, Prof. B.C. Jacobs, Erasmus Universität Rotterdam, Niederlande
2008: Medizinische Doktorarbeit (MD) «Treatment of chronic achilles tendinopathy and ruptures with flexor hallucis tendon transfer: clinical outcome and MRI findings», Prof. C. Gerber, Medizinische Fakultät, Universität Zürich, Schweiz
2007: Staatsexamen, Medizinische Fakultät, Universität Zürich, Schweiz

Seit 2023: Oberarzt mbF, Infektiologie und Spitalhygiene, Universitäts-Kinderspital Zürich, Zürich, Schweiz
2017-2022: Oberarzt, Infektiologie und Spitalhygiene, Universitäts-Kinderspital Zürich, Zürich, Schweiz
2015-2017: Fellow, Infektiologie und Spitalhygiene, Universitäts-Kinderspital Zürich, Zürich, Schweiz
2013-2015: Research Fellowship (SNF), Department of Pediatrics, Division of Pediatric Infectious Diseases and Immunology, Erasmus MC–Sophia Children’s Hospital, University Medical Center, Rotterdam, The Netherlands
2010-2013: Assistenzarzt, Universitäts-Kinderspital Zürich, Zürich, Schweiz
2008-2009: Assistenzarzt, Kinderklinik Stadtspital Triemli, Zürich, Schweiz
2008-2013: Truppenarzt, Schweizer Armee

2016: Facharzt für Infektiologie
2013: Facharzt für Kinder- und Jugendmedizin

2021: Führungs-Lehrgang, Universitäts-Kinderspital Zürich, Zürich, Schweiz
2016: Facharzt für Infektiologie
2015-2017: Fellow, Infektiologie und Spitalhygiene, Universitäts-Kinderspital Zürich, Zürich, Schweiz
2013-2015: Research Fellowship (SNF), Department of Pediatrics, Division of Pediatric Infectious Diseases and Immunology, Erasmus MC–Sophia Children’s Hospital, University Medical Center, Rotterdam, The Netherlands

• 2024: Derrick Edward Award — Recognition for outstanding research in mycoplasmology, International Organization for Mycoplasmology (IOM)
• 2021: Young Investigator Award 2021 in the category of «basic science research», European Society for Pediatric Infectious Diseases (ESPID)
• 2021: Steven Hoogendijk Award 2021, Biannual award for best medical PhD thesis of Erasmus University Rotterdam and Technical University Delft, The Netherlands
• 2020: 1st Prize clinical research in infectious diseases, Swiss Society for Infectious Diseases (SSI) Award 2020
• 2020: Fellowship 2020, Walter and Gertrud Siegenthaler Foundation
• 2020: Science Award 2020, Walter and Gertrud Siegenthaler Foundation
• 2019: 2nd Prize clinical research in infectious diseases, Swiss Society for Infectious Diseases (SSI) Award 2019
• 2019: Swiss Research Network of Clinical Pediatric Hubs (SwissPedNet) Prize 2019, Swiss Society of Pediatrics (SSP)
• 2018: Award for best oral presentation 2018, Children’s Research Center (CRC) Retreat, Children’s University Hospital Zurich
• 2015: Fellowship Award 2015, European Society for Pediatric Infectious Diseases (ESPID)

• International Organization for Mycoplasmology (IOM) International Research Program of Comparative Mycoplasmology (IRPCM) Human Mycoplasmas Team (Chair)
• Committee for Scientific Affairs and Awards (CSAA) European Society for Pediatric Infectious Diseases (ESPID)
• ESCMID Study Group for Mycoplasma and Chlamydia Infections (ESGMAC)
• Geschäftsausschuss Forschungszentrum für das Kind (FZK), Universitäts-Kinderspital Zürich, Zürich, Schweiz
• European Society for Pediatric Infectious Diseases (ESPID) Manual of Childhood Infections, Mitarbeiter «The Blue Book»
• Deutsche Gesellschaft für Pädiatrische Infektiologie (DGPI), Mitarbeiter DGPI Handbuch
• AWMF (Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften e.V. Deutschland), Mitarbeiter Leitlinie «Management der ambulant erworbenen Pneumonie bei Kindern und Jugendlichen (pCAP)»

• ESCMID Study Group for Epidemiological Markers (ESGEM and ESGEM-AMR)
• ESCMID Study Group for Borrelia (ESGBOR)
• European Society of Clinical Microbiology and Infectious Diseases (ESCMID)
• ESCMID Study Group for Mycoplasma and Chlamydia Infections (ESGMAC)
• Membership of the Batavian Society of Experimental Philosophy, The Netherlands
• Swiss Society for Infectious Diseases (SSI)
• German Society of Mycoplasma
• Swiss Society of Pediatric Infectious Diseases (PIGS)
• European Society for Pediatric Infectious Diseases (ESPID)
• Swiss Society of Pediatrics (SSP)

• Pneumonie beim Kind (Pathogenese, Erregerdiagnostik und Therapie)
• Mykoplasmen (Mycoplasma pneumoniae)
• Lyme-Borreliose (Borrelia burgdorferi)
• Akute mukokutane Reaktionen auf Infektionen

• 2024: „Developing a novel method for assessing global genetic diversity and molecular surveillance of Mycoplasma pneumoniae during its re-emergence after the COVID-19 pandemic and beyond“, European Society of Clinical Microbiology and Infectious Diseases (ESCMID)
• 2024: EMDO Foundation Grant 2024, EMDO Stiftung
• 2022: Investigator Initiated Clinical Trials (IICT) «A randomized controlled non-inferiority trial of placebo versus macrolide antibiotics for Mycoplasma pneumoniae infection in children with community-acquired pneumonia (CAP): THE MYTHIC STUDY», Swiss National Science Foundation (SNSF)
• 2021: Young Investigator Award 2021, European Society for Pediatric Infectious Diseases (ESPID)
• 2020: Research fellowship, Walter and Gertrud Siegenthaler Foundation, CH
• 2020: «Filling the Gap» career development program, University of Zurich, CH
• 2019: Research grant, Starr Foundation, USA
• 2018: Research grant, Starr Foundation, USA
• 2017: Wissenschaftliche Oberarztstelle, Promedica Foundation, CH
• 2015: Fellowship Award 2015, European Society for Pediatric Infectious Diseases (ESPID)
• 2014: Research grant, Sophia Scientific Research Foundation NL (SSWO)
• 2013: Postdoc.mobility, Swiss National Science Foundation (SNSF)

• ORCID
• Google Scholar-ID
• Researcher-ID
• Scopus